1. Home
  2. ALTI vs PRLD Comparison

ALTI vs PRLD Comparison

Compare ALTI & PRLD Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo AlTi Global Inc.

ALTI

AlTi Global Inc.

N/A

Current Price

$3.16

Market Cap

492.8M

Sector

Finance

ML Signal

N/A

Logo Prelude Therapeutics Incorporated

PRLD

Prelude Therapeutics Incorporated

N/A

Current Price

$4.48

Market Cap

529.1M

Sector

Health Care

ML Signal

N/A

Company Overview

Basic Information
Metric
ALTI
PRLD
Founded
2020
2016
Country
United States
United States
Employees
490
N/A
Industry
Investment Managers
Medicinal Chemicals and Botanical Products
Sector
Finance
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
492.8M
529.1M
IPO Year
2021
2020

Fundamental Metrics

Financial Performance
Metric
ALTI
PRLD
Price
$3.16
$4.48
Analyst Decision
Strong Buy
Analyst Count
0
3
Target Price
N/A
$5.67
AVG Volume (30 Days)
155.0K
517.2K
Earning Date
05-11-2026
05-13-2026
Dividend Yield
N/A
N/A
EPS Growth
41.11
23.21
EPS
N/A
N/A
Revenue
$254,956,000.00
$12,140,000.00
Revenue This Year
$18.06
$320.10
Revenue Next Year
$10.71
$100.00
P/E Ratio
N/A
N/A
Revenue Growth
23.21
73.43
52 Week Low
$2.75
$0.98
52 Week High
$5.45
$6.83

Technical Indicators

Market Signals
Indicator
ALTI
PRLD
Relative Strength Index (RSI) 36.49 36.21
Support Level $2.87 $3.92
Resistance Level $3.97 $4.69
Average True Range (ATR) 0.21 0.39
MACD -0.08 -0.19
Stochastic Oscillator 21.07 5.19

Price Performance

Historical Comparison
ALTI
PRLD

About ALTI AlTi Global Inc.

AlTi Global Inc is a wealth and investment partner to families, foundations, and institutions, helping clients activate capital, bring structure to complexity, and plan across borders and generations. The company combines the breadth of an international firm with the service offering of a family office to deliver solutions for wealth and capital. It provides services including discretionary and non-discretionary investment advisory, estate and wealth planning, trust and fiduciary, governance, philanthropy, and family office services, along with access to alternative investment opportunities. The company generates revenue from management, advisory, trustee, or administration fees, performance or incentive fees, distributions from investments, and other income or fees.

About PRLD Prelude Therapeutics Incorporated

Prelude Therapeutics Incorp is a precision oncology company developing medicines in areas of high unmet need for cancer patients. Its pipeline features selective KAT6A degraders and mutant selective JAK2V617F JH2 inhibitors, new approaches to clinically validated targets with transformative potential for patients. The company is also leveraging its expertise in targeted protein degradation to discover and develop next-generation degrader antibody conjugates (DACs) with novel payloads.

Share on Social Networks: